263 related articles for article (PubMed ID: 32827713)
1. Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study.
Testaert H; Bouet M; Valour F; Gigandon A; Lafon ME; Philit F; Sénéchal A; Casalegno JS; Blanchard E; Le Pavec J; Ader F
Clin Microbiol Infect; 2021 Jun; 27(6):897-903. PubMed ID: 32827713
[TBL] [Abstract][Full Text] [Related]
2. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
Liu V; Dhillon GS; Weill D
Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 10 years of parainfluenza virus, human metapneumovirus, and respiratory syncytial virus infections in lung transplant recipients.
de Zwart AES; Riezebos-Brilman A; Alffenaar JC; van den Heuvel ER; Gan CT; van der Bij W; Kerstjens HAM; Verschuuren EAM
Am J Transplant; 2020 Dec; 20(12):3529-3537. PubMed ID: 32449200
[TBL] [Abstract][Full Text] [Related]
4. Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency.
Burrows FS; Carlos LM; Benzimra M; Marriott DJ; Havryk AP; Plit ML; Malouf MA; Glanville AR
J Heart Lung Transplant; 2015 Jul; 34(7):958-62. PubMed ID: 25753833
[TBL] [Abstract][Full Text] [Related]
5. Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation.
Li L; Avery R; Budev M; Mossad S; Danziger-Isakov L
J Heart Lung Transplant; 2012 Aug; 31(8):839-44. PubMed ID: 22621746
[TBL] [Abstract][Full Text] [Related]
6. Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy.
Uçkay I; Gasche-Soccal PM; Kaiser L; Stern R; Mazza-Stalder J; Aubert JD; van Delden C
J Heart Lung Transplant; 2010 Mar; 29(3):299-305. PubMed ID: 19837611
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients.
Damlaj M; Bartoo G; Cartin-Ceba R; Gijima D; Alkhateeb HB; Merten J; Hashmi S; Litzow M; Gastineau D; Hogan W; Patnaik MM
Transpl Infect Dis; 2016 Apr; 18(2):216-26. PubMed ID: 26909896
[TBL] [Abstract][Full Text] [Related]
8. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA
J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin prophylaxis after lung transplantation is associated with improved overall survival.
Li D; Duan Q; Weinkauf J; Kapasi A; Varughese R; Hirji A; Lien D; Meyer S; Laing B; Nagendran J; Halloran K
J Heart Lung Transplant; 2020 Dec; 39(12):1426-1434. PubMed ID: 33041181
[TBL] [Abstract][Full Text] [Related]
10. Oral and Inhaled Ribavirin Treatment for Respiratory Syncytial Virus Infection in Lung Transplant Recipients.
Permpalung N; Thaniyavarn T; Saullo JL; Arif S; Miller RA; Reynolds JM; Alexander BD
Transplantation; 2020 Jun; 104(6):1280-1286. PubMed ID: 31568275
[TBL] [Abstract][Full Text] [Related]
11. Montelukast in chronic lung allograft dysfunction after lung transplantation.
Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcomes among lung transplant patients with respiratory syncytial virus infection.
Mahan LD; Points A; Mohanka MR; Bollineni S; Joerns J; Kaza V; La Hoz RM; Gao A; Zhang S; Torres F; Banga A
Transpl Infect Dis; 2021 Aug; 23(4):e13661. PubMed ID: 34159688
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin.
McCurdy LH; Milstone A; Dummer S
J Heart Lung Transplant; 2003 Jul; 22(7):745-53. PubMed ID: 12873542
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection.
Pelaez A; Lyon GM; Force SD; Ramirez AM; Neujahr DC; Foster M; Naik PM; Gal AA; Mitchell PO; Lawrence EC
J Heart Lung Transplant; 2009 Jan; 28(1):67-71. PubMed ID: 19134533
[TBL] [Abstract][Full Text] [Related]
15. Paramyxovirus infection in lung transplant recipients.
Wendt CH; Fox JM; Hertz MI
J Heart Lung Transplant; 1995; 14(3):479-85. PubMed ID: 7654733
[TBL] [Abstract][Full Text] [Related]
16. The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic Rejection.
Combs MP; Luth JE; Falkowski NR; Wheeler DS; Walker NM; Erb-Downward JR; Wakeam E; Sjoding MW; Dunlap DG; Admon AJ; Dickson RP; Lama VN
Am J Respir Crit Care Med; 2024 Jun; 209(11):1360-1375. PubMed ID: 38271553
[No Abstract] [Full Text] [Related]
17. Respiratory Syncytial Virus, Human Metapneumovirus, and Parainfluenza Virus Infections in Lung Transplant Recipients: A Systematic Review of Outcomes and Treatment Strategies.
de Zwart A; Riezebos-Brilman A; Lunter G; Vonk J; Glanville AR; Gottlieb J; Permpalung N; Kerstjens H; Alffenaar JW; Verschuuren E
Clin Infect Dis; 2022 Jul; 74(12):2252-2260. PubMed ID: 35022697
[TBL] [Abstract][Full Text] [Related]
18. ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients.
Gottlieb J; Zamora MR; Hodges T; Musk AW; Sommerwerk U; Dilling D; Arcasoy S; DeVincenzo J; Karsten V; Shah S; Bettencourt BR; Cehelsky J; Nochur S; Gollob J; Vaishnaw A; Simon AR; Glanville AR
J Heart Lung Transplant; 2016 Feb; 35(2):213-21. PubMed ID: 26452996
[TBL] [Abstract][Full Text] [Related]
19. Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.
Foolad F; Aitken SL; Shigle TL; Prayag A; Ghantoji S; Ariza-Heredia E; Chemaly RF
Clin Infect Dis; 2019 May; 68(10):1641-1649. PubMed ID: 30202920
[TBL] [Abstract][Full Text] [Related]
20. Effective use of oral ribavirin for respiratory syncytial viral infections in allogeneic haematopoietic stem cell transplant recipients.
Gorcea CM; Tholouli E; Turner A; Saif M; Davies E; Battersby E; Dignan FL
J Hosp Infect; 2017 Feb; 95(2):214-217. PubMed ID: 28077243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
